Compare GALT & NIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GALT | NIU |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.2M | 234.5M |
| IPO Year | 2008 | 2018 |
| Metric | GALT | NIU |
|---|---|---|
| Price | $2.53 | $2.34 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $8.50 | $3.50 |
| AVG Volume (30 Days) | ★ 348.5K | 343.0K |
| Earning Date | 05-15-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $25.54 |
| Revenue Next Year | N/A | $17.70 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.27 | $2.31 |
| 52 Week High | $7.13 | $5.67 |
| Indicator | GALT | NIU |
|---|---|---|
| Relative Strength Index (RSI) | 54.57 | 31.31 |
| Support Level | $2.09 | $2.31 |
| Resistance Level | $2.60 | $3.28 |
| Average True Range (ATR) | 0.23 | 0.16 |
| MACD | 0.06 | -0.04 |
| Stochastic Oscillator | 44.71 | 4.71 |
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Niu Technologies designs, manufactures, and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycles, mopeds, and bicycle series, including the NQi, MQi, UQi, FQi series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.